Morning Overview on MSN

The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans

Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
Neurology Advisor

FDA Approves Lower-Dose Gadolinium Contrast Agent Ambelvist

The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
Case Western Reserve University

MRI Contrast Agents Accumulate in the Brain

The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast ...
Futurism

MRI Scans Causing Nasty Material to Form Inside Body, Scientists Find

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.
Healio

FDA approves Ambelvist MRI contrast agent with lower dose of gadolinium

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...